市場調査レポート

商品コード

1452859

気道陽圧装置の世界市場：市場規模、シェア、成長分析 - 製品タイプ別、用途別、エンドユーザー別、産業予測（2024～2031年）

Global Positive Airway Pressure Devices Market Size, Share, Growth Analysis, By Product Type, By Application, By End-user - Industry Forecast 2024-2031

出版日: 2024年03月08日 | 発行: SkyQuest

| ページ情報: 英文 219 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 832,842円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 974,268円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,115,694円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の気道陽圧装置の市場規模は、2022年に23億米ドル、2023年に24億3,000万米ドルに達し、2024～2031年の予測期間中にCAGR 5.6%で成長し、2031年には37億6,000万米ドルに達すると予測されています。

気道陽圧（PAP）装置の世界市場は、睡眠時無呼吸症候群のような睡眠関連の呼吸障害に対する世界の認識と診断の高まりによって、着実に拡大しています。健康全般に重大な影響を及ぼす可能性のあるこれらの疾患は、効果的な治療に対する需要を促進しています。持続的気道陽圧（CPAP）および二段階陽圧（BiPAP）装置を含む気道陽圧装置は、呼吸を改善し症状を緩和するための非侵襲的ソリューションを提供します。ヘルスケア支出の増加、機器の快適性と使いやすさを向上させる技術の進歩、睡眠障害の影響を受けやすい高齢者人口の増加などの要因が、市場の成長を促進しています。メーカー、ヘルスケアプロバイダー、研究機関の連携がイノベーションを促進しています。しかし、患者のアドヒアランス、コスト、さまざまな地域における規制の問題などの課題が、市場のダイナミクスを形成しています。こうした課題に対処するため、産業各社は製品の改良、流通の拡大、教育への投資を行い、患者やヘルスケア提供者の間でPAP療法が受け入れられるよう努力しています。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主な投資の分析
主な成功要因
競合の程度

市場力学と見通し

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

世界の気道陽圧装置市場：製品タイプ別

市場概要
CPAP
APAP
BiPAP

世界の気道陽圧装置市場：用途別

市場概要
閉塞性睡眠時無呼吸症候群
呼吸不全
COPD

世界の気道陽圧装置市場：エンドユーザー別

市場概要
睡眠研究所・病院
在宅介護/個人

世界の気道陽圧装置市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2021年）
主な市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

Philips Respironics（US）
Fisher & Paykel Healthcare Ltd.（New Zealand）
Curative Medical Inc.（US）
ResMed（US）
Drive Devilbiss Healthcare Ltd.（UK）
Medtronic, Inc.（US）
Servona GmbH（Germany）
Armstrong Medical（UK）
Medical Depot Inc.（US）
Smith's Group PLC（UK）
Lowenstein Medical UK Ltd（UK）
Breas Medical AB（Sweden）
Apex Medical Corp.（Taiwan）
DeVilbiss Healthcare LLC（US）
Weinmann Medical Technology GmbH+Co. KG（Germany）
BMC Medical Co., Ltd.（China）
Apex Healthcare Berhad（Malaysia）
Compumedics Limited（Australia）
Vyaire Medical, Inc.（US）
Cadwell Industries, Inc.（US）

Product Code: SQMIG35A2480

Global Positive Airway Pressure Devices Market size was valued at USD 2.30 billion in 2022 and is poised to grow from USD 2.43 billion in 2023 to USD 3.76 billion by 2031, growing at a CAGR of 5.6% during the forecast period (2024-2031).

The global market for Positive Airway Pressure (PAP) devices is steadily expanding, driven by increased awareness and diagnosis of sleep-related breathing disorders like sleep apnea worldwide. These conditions, which can significantly affect overall health, are fueling demand for effective treatments. Positive Airway Pressure devices, including Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP) machines, offer non-invasive solutions to improve breathing and alleviate symptoms. Factors such as rising healthcare spending, technological advancements improving device comfort and usability, and a growing elderly population susceptible to sleep disorders are driving market growth. Collaborations among manufacturers, healthcare providers, and research institutions are fostering innovation. However, challenges like patient adherence, cost, and regulatory issues in various regions are shaping market dynamics. To address these challenges, industry players are refining products, expanding distribution, and investing in education to increase acceptance of PAP therapy among patients and healthcare providers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Positive Airway Pressure Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Positive Airway Pressure Devices Market Segmental Analysis

The global positive airway pressure devices market is segmented into four major segments i.e. by Product type, Application, End user and region. Based on Product type, it is divided into CPAP, APAP, BiPAP. Based on Application, it is bifurcated as Obstructive Sleep Apnea, Respiratory Failures, COPD. Based on end user, it is segregated into Sleep Laboratories and Hospitals, Home Care/Individuals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Positive Airway Pressure Devices Market

The increasing prevalence of sleep disorders worldwide has directly impacted the expansion of the positive airway pressure devices market. These devices, crucial in treating conditions like obstructive sleep apnea (OSA), are recognized as the primary approach to managing such disorders. By ensuring unobstructed airflow during sleep, PAP therapy addresses the underlying issues effectively. Consequently, the escalating rates of sleep disorders are expected to fuel the demand for positive airway pressure devices in the foreseeable future, serving as a key driver for market growth.

Restraints in the Global Positive Airway Pressure Devices Market

While PAP devices have proven effective in managing sleep-related breathing disorders such as sleep apnea, many patients face challenges in consistently adhering to their prescribed usage. These hurdles include discomfort from poorly fitting masks, feelings of claustrophobia, and a lack of understanding regarding the long-term health benefits of PAP therapy, all of which contribute to non-compliance. Overcoming these obstacles is crucial to maximizing the efficacy of PAP devices and fostering positive patient outcomes. However, patient adherence continues to present a substantial barrier to the market's expansion and overall success.

Market Trends of the Global Positive Airway Pressure Devices Market

Advancements in healthcare technology have led PAP device manufacturers to incorporate connectivity features into their products, enabling patients to send therapy data to healthcare providers and receive remote feedback. This shift towards remote monitoring not only boosts patient compliance through personalized support but also enhances overall therapy management, reflecting the broader trend in the healthcare industry towards digital healthcare delivery. This trajectory is anticipated to significantly influence the PAP devices market in the foreseeable future.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Positive Airway Pressure Devices Market by Product Type

Market Overview
CPAP
APAP
BiPAP

Global Positive Airway Pressure Devices Market by Application

Market Overview
Obstructive Sleep Apnea
Respiratory Failures
COPD

Global Positive Airway Pressure Devices Market by End-user

Market Overview
Sleep Laboratories and Hospitals
Home Care/Individuals

Global Positive Airway Pressure Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Philips Respironics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fisher & Paykel Healthcare Ltd. (New Zealand)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curative Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ResMed (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Drive Devilbiss Healthcare Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Servona GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Armstrong Medical (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medical Depot Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith's Group PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lowenstein Medical UK Ltd (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Breas Medical AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Apex Medical Corp. (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DeVilbiss Healthcare LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Weinmann Medical Technology GmbH + Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BMC Medical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Apex Healthcare Berhad (Malaysia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Compumedics Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vyaire Medical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cadwell Industries, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments